1. Home
  2. TZOO vs ONCY Comparison

TZOO vs ONCY Comparison

Compare TZOO & ONCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Travelzoo

TZOO

Travelzoo

HOLD

Current Price

$11.42

Market Cap

102.6M

ML Signal

HOLD

Logo Oncolytics Biotech Inc.

ONCY

Oncolytics Biotech Inc.

HOLD

Current Price

$0.86

Market Cap

107.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TZOO
ONCY
Founded
1998
1998
Country
United States
Canada
Employees
N/A
29
Industry
Advertising
Pharmaceuticals and Biotechnology
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
102.6M
107.3M
IPO Year
2003
2002

Fundamental Metrics

Financial Performance
Metric
TZOO
ONCY
Price
$11.42
$0.86
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
4
Target Price
$17.50
$7.33
AVG Volume (30 Days)
133.8K
1.1M
Earning Date
04-23-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.23
N/A
Revenue
N/A
N/A
Revenue This Year
$11.98
N/A
Revenue Next Year
$9.52
$2,505.00
P/E Ratio
$51.13
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.72
$0.77
52 Week High
$14.00
$1.51

Technical Indicators

Market Signals
Indicator
TZOO
ONCY
Relative Strength Index (RSI) 58.77 44.21
Support Level $9.78 $0.79
Resistance Level $11.98 $1.06
Average True Range (ATR) 0.67 0.06
MACD 0.01 -0.00
Stochastic Oscillator 57.33 16.10

Price Performance

Historical Comparison
TZOO
ONCY

About TZOO Travelzoo

Travelzoo acts as a publisher of travel and entertainment offers. It operates in four segments. Travelzoo North America segment, which is the key revenue driver, consists of operations in Canada and the U.S.; Travelzoo Europe segment consists of operations in France, Germany, Spain, and the U.K.; Jack's Flight Club segment consists of subscription revenue from premium members to access and receive flight deals from Jack's Flight Club via email or via Android or Apple mobile applications; and New Initiatives consists of Travelzoo's licensing activities in Asia Pacific territories. It derives its revenue through advertising fees including listing fees paid by travel, entertainment, and local businesses to advertise their offers on the company's media properties.

About ONCY Oncolytics Biotech Inc.

Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer, among others.

Share on Social Networks: